Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36972026

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Jun 8
First author
Mirza MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Jun;20(6):353. doi: 10.1038/s41571-023-00763-0.
    note
    Source null
    related pmid
    37024681
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Aug 31;389(9):866. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646693
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 Aug 31;389(9):866-867. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646694
    relationship
    Comment in
  4. citation
    N Engl J Med. 2023 Aug 31;389(9):867. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646695
    relationship
    Comment in
  5. citation
    N Engl J Med. 2023 Aug 31;389(9):867-868. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646696
    relationship
    Comment in
  6. citation
    CA Cancer J Clin. 2023 Sep-Oct;73(5):445-447. doi: 10.3322/caac.21809.
    note
    Source null
    related pmid
    37665330
    relationship
    Comment in

Authors and identifiers

  1. name
    Mirza MR
    type
    Author
  2. name
    Chase DM
    type
    Author
  3. name
    Slomovitz BM
    type
    Author
  4. name
    dePont Christensen R
    type
    Author
  5. name
    Novák Z
    type
    Author
  6. name
    Black D
    type
    Author
  7. name
    Gilbert L
    type
    Author
  8. name
    Sharma S
    type
    Author
  9. name
    Valabrega G
    type
    Author
  10. name
    Landrum LM
    type
    Author
  11. name
    Hanker LC
    type
    Author
  12. name
    Stuckey A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mirza MR
    type
    Author
  2. name
    Chase DM
    type
    Author
  3. name
    Slomovitz BM
    type
    Author
  4. name
    dePont Christensen R
    type
    Author
  5. name
    Novák Z
    type
    Author
  6. name
    Black D
    type
    Author
  7. name
    Gilbert L
    type
    Author
  8. name
    Sharma S
    type
    Author
  9. name
    Valabrega G
    type
    Author
  10. name
    Landrum LM
    type
    Author
  11. name
    Hanker LC
    type
    Author
  12. name
    Stuckey A
    type
    Author
bibliography ids
  1. nci-bib-699a84e5a7fdf9aa029d0ef4
book metadata
content sha256
6abff50184d5726d9528eb14e6074e70ecdb25b386f86067b35448600b9139d4
document type
citation
dois
  1. 10.1056/NEJMoa2216334
electronic publication date
display
2023 Mar 27
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:36972026
immutable id
pubmed:36972026@6abff50184d5726d9528eb14e6074e70ecdb25b386f86067b35448600b9139d4
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
23
name
The New England journal of medicine
nlm unique id
0255562
pages
2145-2158
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Jun;20(6):353. doi: 10.1038/s41571-023-00763-0.
    note
    Source null
    related pmid
    37024681
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Aug 31;389(9):866. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646693
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 Aug 31;389(9):866-867. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646694
    relationship
    Comment in
  4. citation
    N Engl J Med. 2023 Aug 31;389(9):867. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646695
    relationship
    Comment in
  5. citation
    N Engl J Med. 2023 Aug 31;389(9):867-868. doi: 10.1056/NEJMc2308037.
    note
    Source null
    related pmid
    37646696
    relationship
    Comment in
  6. citation
    CA Cancer J Clin. 2023 Sep-Oct;73(5):445-447. doi: 10.3322/caac.21809.
    note
    Source null
    related pmid
    37665330
    relationship
    Comment in
outcomes validated
false
pmid
36972026
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
1566100bf260bb01ae269e16b8b0aef4a92d049fdc6e2af020139baf16fae6ef
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Jun 8
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36972026/
title
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Preserved source evidence · Not medical advice